IXICO plc has signed a memorandum of understanding or MOU, with the Beijing Union Medical and Pharmaceutical General Corporation, or UMP. The MOU states that IXICO and UMP plan to work together to deploy a neuroimaging informatics platform in China to support dementia diagnosis, to advance public understanding of dementia, and to use imaging biomarkers to enrich study populations to streamline the evaluation of new dementia treatments.